WULF vs. SRPT
Compare and contrast key facts about TeraWulf Inc. (WULF) and Sarepta Therapeutics, Inc. (SRPT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WULF or SRPT.
Key characteristics
| WULF | SRPT | |
|---|---|---|
| YTD Return | 243.75% | 26.11% |
| 1Y Return | 777.66% | 53.64% |
| 3Y Return (Ann) | -34.16% | 11.45% |
| 5Y Return (Ann) | 10.91% | 4.79% |
| 10Y Return (Ann) | -5.43% | 22.86% |
| Sharpe Ratio | 5.98 | 1.04 |
| Sortino Ratio | 4.12 | 2.18 |
| Omega Ratio | 1.46 | 1.27 |
| Calmar Ratio | 7.71 | 0.91 |
| Martin Ratio | 27.39 | 3.74 |
| Ulcer Index | 27.40% | 13.56% |
| Daily Std Dev | 125.57% | 48.76% |
| Max Drawdown | -98.50% | -98.17% |
| Current Drawdown | -77.13% | -31.96% |
Fundamentals
| WULF | SRPT | |
|---|---|---|
| Market Cap | $3.16B | $11.62B |
| EPS | -$0.18 | $1.54 |
| Total Revenue (TTM) | $101.29M | $1.64B |
| Gross Profit (TTM) | $26.55M | $1.40B |
| EBITDA (TTM) | $24.17M | $70.22M |
Correlation
The correlation between WULF and SRPT is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
WULF vs. SRPT - Performance Comparison
In the year-to-date period, WULF achieves a 243.75% return, which is significantly higher than SRPT's 26.11% return. Over the past 10 years, WULF has underperformed SRPT with an annualized return of -5.43%, while SRPT has yielded a comparatively higher 22.86% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WULF vs. SRPT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for TeraWulf Inc. (WULF) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WULF vs. SRPT - Dividend Comparison
Neither WULF nor SRPT has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
WULF TeraWulf Inc. | 0.00% | 0.00% | 0.00% | 33.22% |
SRPT Sarepta Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
WULF vs. SRPT - Drawdown Comparison
The maximum WULF drawdown since its inception was -98.50%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for WULF and SRPT. For additional features, visit the drawdowns tool.
Volatility
WULF vs. SRPT - Volatility Comparison
TeraWulf Inc. (WULF) has a higher volatility of 31.92% compared to Sarepta Therapeutics, Inc. (SRPT) at 8.87%. This indicates that WULF's price experiences larger fluctuations and is considered to be riskier than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
WULF vs. SRPT - Financials Comparison
This section allows you to compare key financial metrics between TeraWulf Inc. and Sarepta Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities